SCHEMBL25147202

SCHEMBL25147202

CC(C)c1cn(C)c(-c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
ADORA2A P29274 2/20 0.41
ADORA2B P29275 2/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
ATM Q13315 1/20 0.39
TSHR P16473 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PDE10A Q9Y233 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
ADORA1 P30542 1/20 0.37
PI4KA P42356 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2224580 0.82 TAAR1 (0.42) MC4RNPC1RAB9ANR1H2NR1H3
SCHEMBL2278129 0.82 PDE3B (0.37) NPC1RAB9ANR1H2NR1H3ADORA2A
SCHEMBL6976337 0.82 HPGD (0.38) MC4RNPC1RAB9ANR1H2NR1H3
SCHEMBL22849636 0.80 ADORA3 (0.39) NPC1RAB9ANR1H2NR1H3ADORA2A
SCHEMBL10099635 0.76 NR1H3 (0.47) NPC1RAB9ANR1H2NR1H3ADORA2A
SCHEMBL8666901 0.75 PTGS2 (0.42) NR1H2NR1H3PDE3BPDE3A
SCHEMBL724249 0.75 PDE3B (0.55) NPC1RAB9ANR1H2NR1H3PDE3B
SCHEMBL27517990 0.73 NR1H2 (0.44) NPC1RAB9ANR1H2NR1H3PDE3B
SCHEMBL5376023 0.73 NPC1 (0.44) NPC1RAB9ANR1H2NR1H3ADORA2A
SCHEMBL27217302 0.73 BRD4 (0.47) NPC1RAB9ANR1H2NR1H3PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117631-A1 HPK1 ANTAGONISTS AND USES THEREOF Nimbus Saturn, Inc. 2023-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117631-A1 HPK1 ANTAGONISTS AND USES THEREOF PDXK, HIPK1, PCK1 MC4R 2492/4885NPC1 354/4885RAB9A 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.